NCT06454994

Brief Summary

The aim of this study is to compare two models of the Nobel Lift range (PDO sutures) with similar PDO devices available on the market, in a split-face comparative study. Each thread model will be used in one indication: upper face (eyebrow lift) or mid-face and lower-face. Aesthetic efficacy of the devices will be evaluated and compared with the Global Aesthetic Improvement Scale (GAIS), jowl laxity scale, subjective evaluation of the patient and photographs during a 12-months period. Safety of the devices and procedures will also be evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 6, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 12, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

9 months

First QC Date

June 6, 2024

Last Update Submit

June 12, 2024

Conditions

Keywords

Lifting threadsEyebrow liftJaw laxity

Outcome Measures

Primary Outcomes (1)

  • Comparison of Global Aesthetic Improvement (GAIS) by the investigator between both products

    Non-inferiority of Noble Lift® threads in comparison with Croquis® thread, in terms of GAIS mean score on Month 3, assessed by an independent blinded investigator on photos (in global and for each indication). GAIS is a scale from 1 (worse) to 5 (very much improved).

    Month 3

Secondary Outcomes (7)

  • Percentages of responders for Global Aesthetic Improvement (GAIS) by the investigator

    Month 3, Month 6, Month 12

  • Percentages of responders for Global Aesthetic Improvement (GAIS) by the subject

    Month 3, Month 6, Month 12

  • Change from baseline of Facial Laxity Rating Scale (FLRS) score

    Month 3, Month 6, Month 12

  • Percentages of subjects satisfied with the intervention using a subjective evaluation questionnaire

    Month 3, Month 6, Month 12

  • Number and percentages of immediate and early skin reactions collected by the subject

    Month 1

  • +2 more secondary outcomes

Study Arms (2)

Noble Lift threads

EXPERIMENTAL
Device: Eyebrow liftDevice: Jaw lift

Croquis threads

ACTIVE COMPARATOR
Device: Eyebrow liftDevice: Jaw lift

Interventions

Upper face lifting

Croquis threadsNoble Lift threads
Jaw liftDEVICE

Mid-face and low-face lifting

Croquis threadsNoble Lift threads

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI comprised between 18.5 and 30
  • No ongoing or planned diet.
  • Group 1: requiring an aesthetic treatment of upper face with resorbable threads.
  • Group 2: Subject requiring an aesthetic treatment of mid-face and lower-face with resorbable threads
  • Subject with dense and not too thin skin.

You may not qualify if:

  • Pregnant or nursing woman or planning a pregnancy during the study;
  • Suffering from a severe or progressive disease or any other pathology that may interfere with the evaluation of the study result and/or subject safety, especially cardiac disorder, non-controlled high blood pressure, diabetes, panic disorders, depression, active auto-immune disease, cold, high fever,…
  • Suffering from malnutrition.
  • Acute inflammatory process or infection, or history of chronic or recurrent infection or inflammation with the potential to interfere with the study results or increase the risk of adverse events.
  • Wound healing disorder or with a disorder that may impact wound healing such as connective tissue or immunosuppressive disorder.
  • History of precancerous lesions/skin malignancies.
  • Active skin disease within 6 months of study entry.
  • Scars, rosacea, herpes, acne, blotches or other pathology in the face, at the investigator appreciation.
  • Predisposed to keloidosis or hypertrophic scarring.
  • Known history of hyper- or hypo-pigmentation in the face.
  • Known history of multiple allergies, allergic/anaphylactic reactions including allergy/ hypersensitivity to lidocaine, anaesthetics of the amide type, the used antiseptic components, the used antibiotic cream components.
  • Known bleeding disorder or is receiving medication that will likely increase the risk of bleeding during treatment.
  • Extensive skin laxity, thin skin and/or severe malar fat sagging.
  • Foreign body sensitivity or known or suspected allergies to implant or instrument materials in particular plastic/biomaterial.
  • Any medication which may interfere, at the interpretation of the investigator, with the study objectives in term of efficacy and safety/tolerance.
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Dr Jeanblanc

Aix-en-Provence, France

Location

Dr Facchinetti

Cannes, France

Location

Dr Converset-Viethel

Lyon, France

Location

Dr Lemmel

Paris, France

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
FACTORIAL
Model Details: Hemi-face, intra-individual study
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2024

First Posted

June 12, 2024

Study Start

June 1, 2024

Primary Completion

March 1, 2025

Study Completion

December 1, 2025

Last Updated

June 13, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations